I hope you're right. I get the feeling they are still just rolling along and now looking for the best way to get a few dollars from the uk challenge rather than changing the world. What we need now more than anything i think is further validation of the myc and cell penetrating technology. At the moment it seems we have achieved some success with omomyc , which we cannot sell, and not much more than that. They promised results on our own proprietry myc inhibitor in november i believe. When the time came all they announced was that they still had proprietry inhibitors that would be further tested- meaning no firm candidate as yet. Since then further updates refer to using omomyc again. Why would they do that if they have a better proprietry compound. Smoke and mirrors again it seems. Yes they could pull an iron out of the fire but for me im just making the classic mistake of staying in hoping to recoup my losses. Im an idiot i know.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)